For the benefit of patients and relatives
At DanCann Pharma, we strive to optimize care and well-being for those given up on. We want to revolutionize health and quality of life for patients with challenges and to enhance access to medicines inspired by nature for the benefit of patients and relatives.
This is our purpose, our tool that provides us with guidance and direction. Our motivation and reason to exist.
Being a relative to patients with little hope can be mentally and physically devastating, as they experience similar desperation and neglect as their loved ones.
By improving the distribution and availability of cannabinoid therapeutics, we can create greater relief opportunities and reduce stress factors that often have become a significant part of their lives.
Danish Pilot Programme
The purpose of the pilot programme is to offer patients a lawful way of testing treatment with medicinal cannabis if they have experienced no benefits from authorised medicines. That is the intention with the programme.
The term for formulated, processed or synthetic cannabis sold as a finished product which has undergone full medical trials, and holds a medical marketing authorization.
The term for cannabinoid-based medicine not holding marketing authorization and therefore, sold as an unlicensed medicine that is supplied through health systems and prescribed by a doctor.
Cannabinoids are the active chemical compounds found in the cannabis plant or synthetic produced compounds that can interact with the human endocannabinoid system.